Skip to content

First-in-Human Dose Study of IOA-244 in patients with advanced or metastatic cancers.

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518404-44-00
Acronym
IOA-244-101
Enrollment
34
Registered
2024-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced solid tumours and metastatic cancers

Interventions

None listed

Sponsors

iOnctura SA
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Italy

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026